Asp Isotopes [ASPI] vs Celanese [CE] Detailed Stock Comparison
Asp Isotopes
NASDAQ
Loading...
Celanese
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Asp Isotopes wins in 8 metrics, Celanese wins in 10 metrics, with 0 ties. Celanese appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Asp Isotopes | Celanese | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -14.17 | 6.78 | Asp Isotopes |
| Price-to-Book Ratio | 15.14 | 1.02 | Celanese |
| Debt-to-Equity Ratio | 84.08 | 234.12 | Asp Isotopes |
| PEG Ratio | -59.53 | 5.05 | Asp Isotopes |
| EV/EBITDA | -23.83 | 10.25 | Asp Isotopes |
| Profit Margin (TTM) | 38.60% | -16.54% | Asp Isotopes |
| Operating Margin (TTM) | -721.89% | 7.41% | Celanese |
| EBITDA Margin (TTM) | N/A | 7.41% | N/A |
| Return on Equity | -115.46% | -24.98% | Celanese |
| Return on Assets (TTM) | -26.14% | 2.66% | Celanese |
| Free Cash Flow (TTM) | $-28.07M | $531.00M | Celanese |
| Dividend Yield | N/A | 2.63% | N/A |
| 1-Year Return | 313.43% | -63.09% | Asp Isotopes |
| Price-to-Sales Ratio (TTM) | 185.28 | 0.53 | Celanese |
| Enterprise Value | $666.51M | $17.94B | Celanese |
| EV/Revenue Ratio | 151.29 | 1.78 | Celanese |
| Gross Profit Margin (TTM) | 29.67% | 19.92% | Asp Isotopes |
| Revenue per Share (TTM) | $0 | $92 | Celanese |
| Earnings per Share (Diluted) | $-0.59 | $-15.12 | Asp Isotopes |
| Beta (Stock Volatility) | 3.38 | 1.14 | Celanese |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Asp Isotopes vs Celanese Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Asp Isotopes | -1.54% | -14.71% | 27.57% | 65.37% | 55.30% | 80.77% |
| Celanese | -7.05% | -17.29% | -16.48% | 6.94% | -29.40% | -29.04% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Asp Isotopes | 313.43% | 218.93% | 218.93% | 218.93% | 218.93% | 218.93% |
| Celanese | -63.09% | -56.20% | -51.92% | -25.27% | 66.90% | 163.29% |
Performance & Financial Health Analysis: Asp Isotopes vs Celanese
| Metric | ASPI | CE |
|---|---|---|
| Market Information | ||
| Market Cap | $816.25M | $5.31B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 4,793,356 | 1,830,360 |
| 90 Day Avg. Volume | 4,457,119 | 1,712,727 |
| Last Close | $8.93 | $48.55 |
| 52 Week Range | $1.86 - $10.82 | $36.29 - $144.59 |
| % from 52W High | -17.47% | -66.42% |
| All-Time High | $10.82 (Jul 25, 2025) | $176.50 (Jan 03, 2022) |
| % from All-Time High | -17.47% | -72.49% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.31% | -0.09% |
| Quarterly Earnings Growth | 0.31% | -0.09% |
| Financial Health | ||
| Profit Margin (TTM) | 0.39% | -0.17% |
| Operating Margin (TTM) | -7.22% | 0.07% |
| Return on Equity (TTM) | -1.15% | -0.25% |
| Debt to Equity (MRQ) | 84.08 | 234.12 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.59 | $47.40 |
| Cash per Share (MRQ) | $0.75 | $8.69 |
| Operating Cash Flow (TTM) | $-16,894,872 | $902.00M |
| Levered Free Cash Flow (TTM) | $-20,013,620 | $520.50M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.63% |
| Last 12-Month Dividend | N/A | $1.43 |
Valuation & Enterprise Metrics Analysis: Asp Isotopes vs Celanese
| Metric | ASPI | CE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -14.17 | 6.78 |
| Forward P/E | -59.53 | 5.05 |
| PEG Ratio | -59.53 | 5.05 |
| Price to Sales (TTM) | 185.28 | 0.53 |
| Price to Book (MRQ) | 15.14 | 1.02 |
| Market Capitalization | ||
| Market Capitalization | $816.25M | $5.31B |
| Enterprise Value | $666.51M | $17.94B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 151.29 | 1.78 |
| Enterprise to EBITDA | -23.83 | 10.25 |
| Risk & Other Metrics | ||
| Beta | 3.38 | 1.14 |
| Book Value per Share (MRQ) | $0.59 | $47.40 |
Financial Statements Comparison: Asp Isotopes vs Celanese
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ASPI | CE |
|---|---|---|
| Revenue/Sales | $1.10M | $2.39B |
| Cost of Goods Sold | $774,765 | $1.91B |
| Gross Profit | $326,840 | $476.00M |
| Research & Development | $1.53M | $31.00M |
| Operating Income (EBIT) | $-7.95M | $175.00M |
| EBITDA | $-8.23M | $364.00M |
| Pre-Tax Income | $-8.53M | $-3.00M |
| Income Tax | $-70,720 | $9.00M |
| Net Income (Profit) | $-8.46M | $-17.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ASPI | CE |
|---|---|---|
| Cash & Equivalents | $55.97M | $951.00M |
| Total Current Assets | $59.03M | $5.42B |
| Total Current Liabilities | $8.18M | $2.80B |
| Long-Term Debt | $36.96M | $12.66B |
| Total Shareholders Equity | $45.73M | $5.62B |
| Retained Earnings | $-64.62M | $11.08B |
| Property, Plant & Equipment | $1.02M | $10.39B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ASPI | CE |
|---|---|---|
| Operating Cash Flow | $-7.16M | $26.00M |
| Capital Expenditures | $-2.36M | N/A |
| Free Cash Flow | $-5.53M | $-65.00M |
| Debt Repayment | $-262,304 | $-3.16B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ASPI | CE |
|---|---|---|
| Shares Short | 16.34M | 6.40M |
| Short Ratio | 4.67 | 3.92 |
| Short % of Float | 0.24% | 0.08% |
| Average Daily Volume (10 Day) | 4,793,356 | 1,830,360 |
| Average Daily Volume (90 Day) | 4,457,119 | 1,712,727 |
| Shares Outstanding | 72.07M | 109.33M |
| Float Shares | 54.53M | 108.80M |
| % Held by Insiders | 0.23% | 0.00% |
| % Held by Institutions | 0.37% | 1.03% |
Dividend Analysis & Yield Comparison: Asp Isotopes vs Celanese
| Metric | ASPI | CE |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.43 |
| Last 12-Month Dividend Yield | N/A | 2.63% |
| 3-Year Avg Annual Dividend | N/A | $2.34 |
| 3-Year Avg Dividend Yield | N/A | 0.53% |
| 3-Year Total Dividends | N/A | $7.01 |
| Ex-Dividend Date | N/A | Feb 25, 2025 |